Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines

Figure 1

Treatment with curcumin or FLLL32 decreased the proliferation of OSA cell lines. A) Canine (OSA8, OSA16, and D17) or human OSA cell lines (SJSA and U2OS) were treated with vehicle, curcumin, or FLLL32 for 72 hours. Proliferation was analyzed using the CyQUANT® cell proliferation assay kit. Proliferation values are listed as a percentage of DMSO control. Experiments were performed in quadruplicate and repeated two times. Statistical analysis of cell proliferation was performed using the Student's t-test. P values of < 0.05 were considered statistically significant.*p < 0.05 B) Canine and human OSA cell lines were treated with DMSO or FLLL32 for 72 hours and analyzed with CyQUANT® to determine proliferation as a percentage of DMSO control. IC50s for FLLL32 were calculated for each cell line using a log curve. Experiments were performed in quadruplicate and repeated two times.

Back to article page